Sponsor:
St. Paul's Hospital, Canada
Code:
NCT06750302
Conditions
Chronic Rhinosinusitis (CRS)
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Interventions
Methoxyflurane - Penthrox
Placebo
Brief summary:
Conditions
Chronic Rhinosinusitis (CRS)
Study ID
NCT06750302
Start date
Nov 24, 2024
Status verified date
Dec, 2024
Completion date
Jun 24, 2026
Anticipated
Primary completion date
Apr 24, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 19+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
active comparator: Penthrox
placebo comparator: Placebo
Interventions
Methoxyflurane - Penthrox
Placebo
Primary outcome measure
Central contacts
Locations
St Paul's Sinus Centre
Recruiting
Vancouver, British Columbia, Canada, V6Z 1Y6
Contacts
Sponsor
St. Paul's Hospital, Canada
Last update posted
May 15, 2025
Last verified
Dec, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by St. Paul's Hospital, Canada on 2025-05-15.